| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | MHC class I receptor activity | LILRB2 LILRB1 KIR2DS5 KIR3DL1 KIR3DS1 LILRA1 LILRA3 LILRA2 LILRA4 | 2.27e-14 | 18 | 189 | 9 | GO:0032393 |
| GeneOntologyMolecularFunction | inhibitory MHC class I receptor activity | 2.66e-14 | 12 | 189 | 8 | GO:0032396 | |
| GeneOntologyMolecularFunction | MHC class Ib protein binding | 6.70e-13 | 16 | 189 | 8 | GO:0023029 | |
| GeneOntologyMolecularFunction | MHC class Ib receptor activity | 3.84e-12 | 19 | 189 | 8 | GO:0032394 | |
| GeneOntologyMolecularFunction | immune receptor activity | LILRB2 LILRB1 GFRA3 KIR2DL1 KIR2DL3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 LILRA1 LILRA3 LILRA2 IL4R LILRA4 IL9R | 5.27e-11 | 165 | 189 | 15 | GO:0140375 |
| GeneOntologyMolecularFunction | HLA-B specific inhibitory MHC class I receptor activity | 4.29e-10 | 6 | 189 | 5 | GO:0030109 | |
| GeneOntologyMolecularFunction | IgM binding | 3.18e-08 | 11 | 189 | 5 | GO:0001791 | |
| GeneOntologyMolecularFunction | HLA-A specific inhibitory MHC class I receptor activity | 3.86e-08 | 5 | 189 | 4 | GO:0030107 | |
| GeneOntologyMolecularFunction | MHC protein binding | 7.10e-08 | 58 | 189 | 8 | GO:0042287 | |
| GeneOntologyMolecularFunction | MHC class Ib protein complex binding | 2.66e-07 | 7 | 189 | 4 | GO:0023025 | |
| GeneOntologyMolecularFunction | coreceptor activity | 3.96e-07 | 72 | 189 | 8 | GO:0015026 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 2.14e-05 | 36 | 189 | 5 | GO:0019865 | |
| GeneOntologyMolecularFunction | SH2 domain binding | 1.31e-04 | 52 | 189 | 5 | GO:0042169 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | ERBB2 LILRB2 KIR2DS2 LILRB1 GFRA3 PTPRD PTPRZ1 PKD1 FGFR4 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 LILRA1 LILRA3 LILRA2 DRD5 TAS1R2 FCRL4 FCRL5 IL4R LILRA4 IL9R SORL1 | 1.88e-04 | 1353 | 189 | 27 | GO:0004888 |
| GeneOntologyMolecularFunction | MHC class I protein binding | 2.27e-04 | 32 | 189 | 4 | GO:0042288 | |
| GeneOntologyMolecularFunction | protein phosphatase 1 binding | 3.24e-04 | 35 | 189 | 4 | GO:0008157 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 4.02e-04 | 37 | 189 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 4.21e-04 | 102 | 189 | 6 | GO:0001540 | |
| GeneOntologyMolecularFunction | MHC protein complex binding | 5.99e-04 | 41 | 189 | 4 | GO:0023023 | |
| GeneOntologyMolecularFunction | beta-galactosidase activity | 8.75e-04 | 5 | 189 | 2 | GO:0004565 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 8.97e-04 | 210 | 189 | 8 | GO:0019903 | |
| GeneOntologyMolecularFunction | phosphatase binding | 9.54e-04 | 264 | 189 | 9 | GO:0019902 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | GAPVD1 SPP1 LILRB2 LILRB1 PROM1 PTPRD PTPRZ1 PI4KA NECTIN1 IGSF9 LILRA1 LILRA2 DCHS1 CDH1 | 1.75e-03 | 599 | 189 | 14 | GO:0050839 |
| GeneOntologyMolecularFunction | tumor necrosis factor binding | 1.81e-03 | 7 | 189 | 2 | GO:0043120 | |
| GeneOntologyMolecularFunction | galactosidase activity | 1.81e-03 | 7 | 189 | 2 | GO:0015925 | |
| GeneOntologyMolecularFunction | aspartic endopeptidase activity, intramembrane cleaving | 2.40e-03 | 8 | 189 | 2 | GO:0042500 | |
| GeneOntologyBiologicalProcess | immune response-regulating signaling pathway | LILRB2 KIR2DS2 IRF2 LILRB1 KIR2DL5B NFATC2 PTPRS EIF2B5 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 LILRA1 LILRA3 LILRA2 AP3B1 EPG5 KIR3DX1 KIR2DL5A FCRL5 LILRA4 | 1.37e-10 | 615 | 193 | 26 | GO:0002764 |
| GeneOntologyBiologicalProcess | regulation of immune response | TNFSF13 PSG3 LILRB2 SREBF1 KIR2DS2 IRF2 LILRB1 JAK2 PTPRD KIR2DL5B NFATC2 PTPRS EIF2B5 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 LILRA1 LILRA3 LILRA2 AP3B1 EPG5 SPPL2A KIR3DX1 KIR2DL5A FCRL5 IL4R LILRA4 | 1.92e-09 | 1085 | 193 | 33 | GO:0050776 |
| GeneOntologyBiologicalProcess | interleukin-10-mediated signaling pathway | 3.01e-08 | 11 | 193 | 5 | GO:0140105 | |
| GeneOntologyBiologicalProcess | negative regulation of cell development | ERBB2 PSG3 SPP1 LILRB2 TRPC6 DPYSL5 LILRB1 BTG2 PTPRS RAG2 LILRA1 LILRA2 CDH1 IL4R LILRA4 SORL1 | 2.33e-07 | 353 | 193 | 16 | GO:0010721 |
| GeneOntologyBiologicalProcess | positive regulation of long-term synaptic depression | 6.91e-06 | 14 | 193 | 4 | GO:1900454 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte differentiation | 1.28e-05 | 151 | 193 | 9 | GO:1902106 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 1.85e-05 | 59 | 193 | 6 | GO:0045671 | |
| GeneOntologyBiologicalProcess | negative regulation of hemopoiesis | 1.94e-05 | 159 | 193 | 9 | GO:1903707 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase I | 2.33e-05 | 37 | 193 | 5 | GO:0045943 | |
| GeneOntologyBiologicalProcess | long-term synaptic depression | 5.50e-05 | 44 | 193 | 5 | GO:0060292 | |
| GeneOntologyBiologicalProcess | regulation of long-term synaptic depression | 5.72e-05 | 23 | 193 | 4 | GO:1900452 | |
| GeneOntologyBiologicalProcess | immune response-inhibiting cell surface receptor signaling pathway | 9.22e-05 | 10 | 193 | 3 | GO:0002767 | |
| GeneOntologyBiologicalProcess | regulation of cell development | ERBB2 PSG3 SPP1 LILRB2 TRPC6 DPYSL5 ACE LILRB1 SERPINE2 BTG2 PTPRD PTPRS PTPRZ1 RAC1 RAC3 RAG2 LILRA1 LILRA2 AP3B1 CDH1 IL4R CUX1 LILRA4 SORL1 | 9.35e-05 | 1095 | 193 | 24 | GO:0060284 |
| GeneOntologyBiologicalProcess | regulation of transcription by RNA polymerase I | 1.03e-04 | 50 | 193 | 5 | GO:0006356 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level homeostasis | SART3 ERCC6 PSG3 SPP1 LILRB2 LILRB1 JAK2 PASK PROM1 HEPHL1 USH2A DYNC1H1 RAC1 RAC2 RAC3 LILRA1 LILRA2 NCSTN AP3B1 USH1C EPG5 IL4R SORL1 | 1.21e-04 | 1043 | 193 | 23 | GO:0048871 |
| GeneOntologyBiologicalProcess | myeloid dendritic cell differentiation | 1.28e-04 | 28 | 193 | 4 | GO:0043011 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion | 1.37e-04 | 252 | 193 | 10 | GO:0022408 | |
| GeneOntologyBiologicalProcess | cerebral cortex neuron differentiation | 1.47e-04 | 29 | 193 | 4 | GO:0021895 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 1.47e-04 | 85 | 193 | 6 | GO:0002762 | |
| GeneOntologyBiologicalProcess | immune response-inhibiting signal transduction | 1.67e-04 | 12 | 193 | 3 | GO:0002765 | |
| GeneOntologyBiologicalProcess | neuron projection development | DLG5 ERBB2 ERCC6 SPP1 TRPC6 DPYSL5 NCAM2 GFRA3 PTK6 JAK2 SERPINE2 BTG2 PTPRD PTPRS PTPRZ1 NECTIN1 OLFM1 IGSF9 RASAL1 RAC1 RAC3 CECR2 USH1C CDH1 DCLK1 CUX1 | 1.71e-04 | 1285 | 193 | 26 | GO:0031175 |
| GeneOntologyBiologicalProcess | postsynapse assembly | 2.41e-04 | 93 | 193 | 6 | GO:0099068 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ERBB2 SPP1 TRPC6 DPYSL5 GFRA3 PTPRD PTPRS PTPRZ1 NECTIN1 PTPRQ OLFM1 IGSF9 RAC1 RAC3 USH1C CDH1 DCLK1 CUX1 | 2.43e-04 | 748 | 193 | 18 | GO:0048667 |
| GeneOntologyBiologicalProcess | membrane protein intracellular domain proteolysis | 2.72e-04 | 14 | 193 | 3 | GO:0031293 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell differentiation | 2.86e-04 | 96 | 193 | 6 | GO:0060113 | |
| GeneOntologyBiologicalProcess | retina homeostasis | 3.32e-04 | 64 | 193 | 5 | GO:0001895 | |
| GeneOntologyCellularComponent | Fc-epsilon receptor I complex | 8.86e-09 | 9 | 198 | 5 | GO:0032998 | |
| GeneOntologyCellularComponent | Fc receptor complex | 5.44e-08 | 12 | 198 | 5 | GO:0032997 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | ERBB2 ATP6AP1 INPP4A LILRB2 SREBF1 SLC5A7 SLC39A13 PEF1 TBC1D4 PTPRS PI4KA NPC1L1 PKD1 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 RAC1 RAC2 LILRA3 UBR4 ATP13A5 NCSTN AP3B1 SEC31B ATAD3B SPPL2A SORL1 | 4.38e-05 | 1307 | 198 | 28 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | ERBB2 ATP6AP1 INPP4A LILRB2 SREBF1 SLC5A7 SLC39A13 PEF1 TBC1D4 PTPRS PI4KA NPC1L1 PKD1 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 RAC1 RAC2 LILRA3 UBR4 ATP13A5 NCSTN AP3B1 SEC31B ATAD3B SPPL2A SORL1 | 5.56e-05 | 1325 | 198 | 28 | GO:0012506 |
| GeneOntologyCellularComponent | external side of plasma membrane | TNFSF13 PSG3 LILRB2 ACE LILRB1 GFRA3 LILRA1 LILRA2 MUC16 FCRL4 FCRL5 LY9 LY75 IL4R IL9R | 1.34e-04 | 519 | 198 | 15 | GO:0009897 |
| GeneOntologyCellularComponent | ficolin-1-rich granule membrane | 2.80e-04 | 61 | 198 | 5 | GO:0101003 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 2.86e-04 | 223 | 198 | 9 | GO:0098862 | |
| GeneOntologyCellularComponent | membrane protein complex | ERBB2 ATP6AP1 PSG3 LILRB2 TRPC6 LILRB1 JAK2 PEF1 TRPM5 TOMM40L SCN3A PKD1 OLFM1 RAC1 RAC2 RAC3 CACNA1D LILRA1 LILRA2 DPP10 NCSTN AP3B1 SEC31B AKTIP MTX2 DCHS1 CDH1 LILRA4 | 4.29e-04 | 1498 | 198 | 28 | GO:0098796 |
| GeneOntologyCellularComponent | plasma membrane protein complex | ERBB2 PSG3 LILRB2 LILRB1 JAK2 SCN3A OLFM1 RAC1 RAC2 RAC3 CACNA1D LILRA1 LILRA2 DPP10 NCSTN DCHS1 CDH1 LILRA4 | 5.03e-04 | 785 | 198 | 18 | GO:0098797 |
| GeneOntologyCellularComponent | NADPH oxidase complex | 6.15e-04 | 18 | 198 | 3 | GO:0043020 | |
| GeneOntologyCellularComponent | side of membrane | TNFSF13 PSG3 LILRB2 NCAM2 ACE LILRB1 GFRA3 JAK2 LILRA1 LILRA2 MUC16 SPPL2A FCRL4 FCRL5 LY9 LY75 CDH1 IL4R IL9R | 6.80e-04 | 875 | 198 | 19 | GO:0098552 |
| GeneOntologyCellularComponent | cell projection membrane | ERBB2 PSG3 ACE PROM1 PTPRZ1 NPC1L1 PKD1 EPS8L3 USH2A RAC1 CACNA1D DRD5 | 8.71e-04 | 431 | 198 | 12 | GO:0031253 |
| GeneOntologyCellularComponent | cell surface | TNFSF13 PSG3 LILRB2 ACE LILRB1 GFRA3 PROM1 PKD1 MMP7 CACNA1D LILRA1 LILRA2 MUC16 PLA2R1 FCRL4 FCRL5 LY9 LY75 CDH1 IL4R IL9R SORL1 | 8.78e-04 | 1111 | 198 | 22 | GO:0009986 |
| GeneOntologyCellularComponent | stereocilium bundle | 9.26e-04 | 79 | 198 | 5 | GO:0032421 | |
| GeneOntologyCellularComponent | early endosome membrane | 9.62e-04 | 212 | 198 | 8 | GO:0031901 | |
| GeneOntologyCellularComponent | stereocilia ankle link | 1.31e-03 | 6 | 198 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 1.31e-03 | 6 | 198 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | actin-based cell projection | 1.38e-03 | 278 | 198 | 9 | GO:0098858 | |
| GeneOntologyCellularComponent | ATPase complex | 1.45e-03 | 129 | 198 | 6 | GO:1904949 | |
| GeneOntologyCellularComponent | apical part of cell | ERBB2 PSG3 MYO7B SPP1 SLC5A7 PROM1 NPC1L1 PTPRQ USH2A CACNA1D NAALADL1 USH1C DCHS1 CDH1 | 1.59e-03 | 592 | 198 | 14 | GO:0045177 |
| GeneOntologyCellularComponent | lateral loop | 1.82e-03 | 7 | 198 | 2 | GO:0043219 | |
| GeneOntologyCellularComponent | early endosome | ERBB2 INPP4A SLC5A7 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 RAC1 NCSTN AP3B1 WDFY4 SORL1 | 2.20e-03 | 481 | 198 | 12 | GO:0005769 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 2.21e-03 | 96 | 198 | 5 | GO:0070603 | |
| GeneOntologyCellularComponent | stereocilia coupling link | 2.41e-03 | 8 | 198 | 2 | GO:0002139 | |
| HumanPheno | Abnormal peritoneum morphology | 1.12e-05 | 65 | 62 | 7 | HP:0002585 | |
| MousePheno | abnormal visual cortex morphology | 4.17e-07 | 16 | 143 | 5 | MP:0000805 | |
| MousePheno | abnormal occipital lobe morphology | 8.04e-07 | 18 | 143 | 5 | MP:0000804 | |
| MousePheno | decreased length of allograft survival | 1.27e-06 | 9 | 143 | 4 | MP:0004752 | |
| MousePheno | abnormal dendritic cell differentiation | 4.48e-05 | 20 | 143 | 4 | MP:0008115 | |
| MousePheno | abnormal T-helper 2 physiology | 6.16e-05 | 67 | 143 | 6 | MP:0005466 | |
| Domain | ig | PSG3 KIR2DS2 NCAM2 LILRB1 PTPRD PTPRS NECTIN1 FGFR4 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 LILRA1 LILRA3 LILRA2 KIR2DL5A FCRL4 FCRL5 LILRA4 | 1.58e-19 | 190 | 191 | 24 | PF00047 |
| Domain | Immunoglobulin | PSG3 KIR2DS2 NCAM2 LILRB1 PTPRD PTPRS NECTIN1 FGFR4 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 LILRA1 LILRA3 LILRA2 KIR2DL5A FCRL4 FCRL5 LILRA4 | 1.58e-19 | 190 | 191 | 24 | IPR013151 |
| Domain | IG | PSG3 LILRB2 KIR2DS2 NCAM2 LILRB1 PTPRD PTPRS NECTIN1 IGSF9 FGFR4 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 LILRA1 LILRA3 LILRA2 KIR2DL5A FCRL4 FCRL5 LY9 LILRA4 | 2.59e-14 | 421 | 191 | 27 | SM00409 |
| Domain | Ig_sub | PSG3 LILRB2 KIR2DS2 NCAM2 LILRB1 PTPRD PTPRS NECTIN1 IGSF9 FGFR4 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 LILRA1 LILRA3 LILRA2 KIR2DL5A FCRL4 FCRL5 LY9 LILRA4 | 2.59e-14 | 421 | 191 | 27 | IPR003599 |
| Domain | Ig-like_fold | PSG3 LILRB2 KIR2DS2 NCAM2 LILRB1 PTPRD NFATC2 PTPRS PTPRZ1 NECTIN1 IGSF9 FGFR4 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 USH2A LILRA1 LILRA3 LILRA2 KIR2DL5A FCRL4 FCRL5 LY9 IL4R LILRA4 IL9R SORL1 | 2.24e-13 | 706 | 191 | 33 | IPR013783 |
| Domain | - | PSG3 KIR2DS2 NCAM2 LILRB1 PTPRD NFATC2 PTPRS PTPRZ1 NECTIN1 IGSF9 FGFR4 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1 USH2A LILRA1 LILRA3 LILRA2 KIR2DL5A FCRL4 FCRL5 LY9 IL4R LILRA4 IL9R SORL1 | 1.30e-12 | 663 | 191 | 31 | 2.60.40.10 |
| Domain | Ig-like_dom | PSG3 LILRB2 KIR2DS2 NCAM2 LILRB1 PTPRD PTPRS NECTIN1 IGSF9 FGFR4 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 LILRA1 LILRA3 LILRA2 KIR2DL5A FCRL4 FCRL5 LY9 LILRA4 | 1.79e-12 | 503 | 191 | 27 | IPR007110 |
| Domain | IG_LIKE | PSG3 LILRB2 KIR2DS2 NCAM2 LILRB1 PTPRD PTPRS NECTIN1 IGSF9 FGFR4 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 LILRA1 LILRA3 LILRA2 KIR2DL5A FCRL4 FCRL5 LY9 LILRA4 | 6.50e-12 | 491 | 191 | 26 | PS50835 |
| Domain | IGc2 | PSG3 NCAM2 LILRB1 PTPRD PTPRS NECTIN1 IGSF9 FGFR4 LILRA1 LILRA3 LILRA2 FCRL4 FCRL5 LILRA4 | 1.43e-07 | 235 | 191 | 14 | SM00408 |
| Domain | Ig_sub2 | PSG3 NCAM2 LILRB1 PTPRD PTPRS NECTIN1 IGSF9 FGFR4 LILRA1 LILRA3 LILRA2 FCRL4 FCRL5 LILRA4 | 1.43e-07 | 235 | 191 | 14 | IPR003598 |
| Domain | A1B_glyco/leuk_Ig-like_rcpt | 1.56e-07 | 6 | 191 | 4 | IPR016332 | |
| Domain | Ig_2 | 7.87e-07 | 73 | 191 | 8 | PF13895 | |
| Domain | FRG2 | 1.05e-06 | 3 | 191 | 3 | PF15315 | |
| Domain | FRG2 | 1.05e-06 | 3 | 191 | 3 | IPR026245 | |
| Domain | DUF4599 | 4.92e-06 | 12 | 191 | 4 | PF15371 | |
| Domain | DUF4599 | 4.92e-06 | 12 | 191 | 4 | IPR027970 | |
| Domain | FN3 | 2.15e-04 | 199 | 191 | 9 | PS50853 | |
| Domain | FN3_dom | 3.09e-04 | 209 | 191 | 9 | IPR003961 | |
| Domain | CHD_N | 3.10e-04 | 3 | 191 | 2 | IPR012958 | |
| Domain | CHD_C2 | 3.10e-04 | 3 | 191 | 2 | IPR012957 | |
| Domain | CHDCT2 | 3.10e-04 | 3 | 191 | 2 | PF08074 | |
| Domain | CHDNT | 3.10e-04 | 3 | 191 | 2 | PF08073 | |
| Domain | DUF1086 | 3.10e-04 | 3 | 191 | 2 | IPR009462 | |
| Domain | DUF1087 | 3.10e-04 | 3 | 191 | 2 | IPR009463 | |
| Domain | DUF1087 | 3.10e-04 | 3 | 191 | 2 | PF06465 | |
| Domain | DUF1086 | 3.10e-04 | 3 | 191 | 2 | PF06461 | |
| Domain | DUF1087 | 3.10e-04 | 3 | 191 | 2 | SM01147 | |
| Domain | DUF1086 | 3.10e-04 | 3 | 191 | 2 | SM01146 | |
| Domain | C-type_lectin-like/link | 5.39e-04 | 99 | 191 | 6 | IPR016186 | |
| Domain | Glyco_hydro_35 | 6.16e-04 | 4 | 191 | 2 | PF01301 | |
| Domain | GLYCOSYL_HYDROL_F35 | 6.16e-04 | 4 | 191 | 2 | PS01182 | |
| Domain | Gly_Hdrlase_35_cat | 6.16e-04 | 4 | 191 | 2 | IPR031330 | |
| Domain | Glycoside_Hdrlase_35 | 6.16e-04 | 4 | 191 | 2 | IPR001944 | |
| Domain | REJ | 6.16e-04 | 4 | 191 | 2 | PS51111 | |
| Domain | B-gal_1-like | 6.16e-04 | 4 | 191 | 2 | IPR026283 | |
| Domain | REJ_dom | 6.16e-04 | 4 | 191 | 2 | IPR014010 | |
| Domain | FN3 | 6.47e-04 | 185 | 191 | 8 | SM00060 | |
| Domain | CTDL_fold | 8.13e-04 | 107 | 191 | 6 | IPR016187 | |
| Domain | RHO | 1.06e-03 | 20 | 191 | 3 | PS51420 | |
| Domain | C_TYPE_LECTIN_1 | 1.37e-03 | 80 | 191 | 5 | PS00615 | |
| Domain | fn3 | 1.41e-03 | 162 | 191 | 7 | PF00041 | |
| Domain | - | 1.45e-03 | 48 | 191 | 4 | 2.120.10.80 | |
| Domain | PKD/REJ-like | 1.52e-03 | 6 | 191 | 2 | IPR002859 | |
| Domain | REJ | 1.52e-03 | 6 | 191 | 2 | PF02010 | |
| Domain | Lectin_C | 1.71e-03 | 84 | 191 | 5 | PF00059 | |
| Domain | CLECT | 1.71e-03 | 84 | 191 | 5 | SM00034 | |
| Domain | C_TYPE_LECTIN_2 | 1.80e-03 | 85 | 191 | 5 | PS50041 | |
| Domain | C-type_lectin-like | 1.89e-03 | 86 | 191 | 5 | IPR001304 | |
| Domain | ZnF_UBR1 | 2.11e-03 | 7 | 191 | 2 | SM00396 | |
| Domain | ZF_UBR | 2.11e-03 | 7 | 191 | 2 | PS51157 | |
| Domain | zf-UBR | 2.11e-03 | 7 | 191 | 2 | PF02207 | |
| Domain | Znf_UBR | 2.11e-03 | 7 | 191 | 2 | IPR003126 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | NFATC2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 RAC1 RAC2 RAC3 KIR2DL5A | 6.19e-10 | 137 | 135 | 13 | M5669 |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR2DL5A | 1.56e-07 | 88 | 135 | 9 | M16004 |
| Pathway | REACTOME_DAP12_INTERACTIONS | 2.48e-07 | 46 | 135 | 7 | M27151 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | LILRB2 KIR2DS2 LILRB1 KIR2DL1 KIR2DL3 KIR2DS1 KIR3DL1 LILRA1 LILRA3 LILRA2 CDH1 LILRA4 | 2.77e-07 | 190 | 135 | 12 | M8240 |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GH_TO_ITGA_B_RHOA_SIGNALING_PATHWAY | 2.92e-05 | 7 | 135 | 3 | M47538 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | UBR1 LILRB2 KIR2DS2 LILRB1 NFATC2 CDC16 KIR2DL1 KIR2DL3 KIR2DS1 KIR3DL1 HECTD1 DYNC1H1 RAC1 LRRC41 LILRA1 LILRA3 LILRA2 UBR4 RNF25 CDH1 LILRA4 | 3.84e-05 | 828 | 135 | 21 | M1058 |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 4.25e-05 | 41 | 135 | 5 | M13519 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 6.94e-05 | 73 | 135 | 6 | M638 | |
| Pathway | WP_SPINAL_CORD_INJURY | 7.89e-05 | 108 | 135 | 7 | MM15954 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGG_FCGR_RAC_SIGNALING_PATHWAY | 9.81e-05 | 10 | 135 | 3 | M47727 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 1.62e-04 | 54 | 135 | 5 | MM14871 | |
| Pathway | WP_RALA_DOWNSTREAM_REGULATED_GENES | 1.77e-04 | 12 | 135 | 3 | M39408 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | ERBB2 ATP6AP1 SPP1 COL6A5 CHD4 PTK6 JAK2 PTPRZ1 FGFR4 RAC1 RANBP9 NCSTN FAM83B | 1.87e-04 | 418 | 135 | 13 | MM15587 |
| Pubmed | KIR2DS2 KIR2DL5B KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 1.21e-26 | 13 | 200 | 12 | 19120281 | |
| Pubmed | Multiple sclerosis associates with LILRA3 deletion in Spanish patients. | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 LILRA3 KIR2DL5A | 8.43e-26 | 14 | 200 | 12 | 19421224 |
| Pubmed | [Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients]. | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 1.72e-25 | 11 | 200 | 11 | 19664392 |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 2.06e-24 | 12 | 200 | 11 | 19936734 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 2.06e-24 | 12 | 200 | 11 | 20371502 | |
| Pubmed | Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. | KIR2DS2 KIR2DL5B KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 5.65e-24 | 17 | 200 | 12 | 20878400 |
| Pubmed | KIR2DS2 KIR2DL5B KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 5.65e-24 | 17 | 200 | 12 | 19450876 | |
| Pubmed | KIR2DS2 KIR2DL5B KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 5.65e-24 | 17 | 200 | 12 | 19761533 | |
| Pubmed | KIR2DS2 KIR2DL5B KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 5.65e-24 | 17 | 200 | 12 | 20650299 | |
| Pubmed | [Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese]. | KIR2DS2 KIR2DL5B KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 5.65e-24 | 17 | 200 | 12 | 19218127 |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 1.33e-23 | 13 | 200 | 11 | 18687225 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 6.17e-23 | 14 | 200 | 11 | 19875891 | |
| Pubmed | Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 6.17e-23 | 14 | 200 | 11 | 15896204 |
| Pubmed | Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay. | KIR2DS2 KIR2DL5B KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 1.13e-22 | 20 | 200 | 12 | 20193031 |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 2.30e-22 | 15 | 200 | 11 | 20082646 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 2.30e-22 | 15 | 200 | 11 | 19850842 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 2.30e-22 | 15 | 200 | 11 | 20356536 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 2.30e-22 | 15 | 200 | 11 | 19926642 | |
| Pubmed | Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma. | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 2.30e-22 | 15 | 200 | 11 | 20207982 |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 2.30e-22 | 15 | 200 | 11 | 19493232 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 2.30e-22 | 15 | 200 | 11 | 20643584 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 2.30e-22 | 15 | 200 | 11 | 19326408 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 3.45e-22 | 11 | 200 | 10 | 18830515 | |
| Pubmed | KIR2DS2 KIR2DL5B KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 5.76e-22 | 22 | 200 | 12 | 20492596 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 7.33e-22 | 16 | 200 | 11 | 19897003 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 7.33e-22 | 16 | 200 | 11 | 19309280 | |
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population]. | KIR2DS2 KIR2DL5B KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR2DL5A | 7.33e-22 | 16 | 200 | 11 | 16403292 |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 7.33e-22 | 16 | 200 | 11 | 20652381 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 7.33e-22 | 16 | 200 | 11 | 17868255 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 7.33e-22 | 16 | 200 | 11 | 20331834 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 7.33e-22 | 16 | 200 | 11 | 19000141 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 7.33e-22 | 16 | 200 | 11 | 20670355 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 7.33e-22 | 16 | 200 | 11 | 18668235 | |
| Pubmed | Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage. | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 7.33e-22 | 16 | 200 | 11 | 19527230 |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 7.33e-22 | 16 | 200 | 11 | 19279038 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 7.33e-22 | 16 | 200 | 11 | 18643961 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 7.33e-22 | 16 | 200 | 11 | 20210919 | |
| Pubmed | Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome. | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 | 2.06e-21 | 12 | 200 | 10 | 19181658 |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 2.06e-21 | 12 | 200 | 10 | 20137308 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 2.07e-21 | 17 | 200 | 11 | 19968064 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 2.07e-21 | 17 | 200 | 11 | 20483367 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 2.07e-21 | 17 | 200 | 11 | 20173792 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 2.07e-21 | 17 | 200 | 11 | 19169284 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 5.29e-21 | 18 | 200 | 11 | 20580654 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 5.29e-21 | 18 | 200 | 11 | 20519398 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 5.29e-21 | 18 | 200 | 11 | 19846535 | |
| Pubmed | Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis. | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 5.29e-21 | 18 | 200 | 11 | 19630074 |
| Pubmed | KIR2DS2 KIR2DL5B KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR2DL5A | 5.29e-21 | 18 | 200 | 11 | 20200544 | |
| Pubmed | Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians. | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 5.29e-21 | 18 | 200 | 11 | 19046302 |
| Pubmed | KIR2DS2 KIR2DL5B KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A IL4R | 6.69e-21 | 35 | 200 | 13 | 19683555 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 | 8.88e-21 | 13 | 200 | 10 | 19934297 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 1.25e-20 | 19 | 200 | 11 | 20600442 | |
| Pubmed | KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease. | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 1.25e-20 | 19 | 200 | 11 | 18571006 |
| Pubmed | Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil. | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 1.25e-20 | 19 | 200 | 11 | 18778326 |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 1.25e-20 | 19 | 200 | 11 | 18848853 | |
| Pubmed | KIR2DS2 KIR2DL5B KIR2DL1 KIR2DL2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 2.76e-20 | 20 | 200 | 11 | 20426625 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1 KIR2DL5A | 3.09e-20 | 14 | 200 | 10 | 19489269 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 5.78e-20 | 21 | 200 | 11 | 19861144 | |
| Pubmed | KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations. | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR2DL5A | 9.23e-20 | 15 | 200 | 10 | 17498266 |
| Pubmed | KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 5.92e-19 | 17 | 200 | 10 | 19032228 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DS1 KIR2DL5A | 5.92e-19 | 17 | 200 | 10 | 20173784 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 | 1.04e-18 | 8 | 200 | 8 | 18681957 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 1.32e-18 | 18 | 200 | 10 | 20210918 | |
| Pubmed | Immunogenetic characteristics of patients with autoimmune gastritis. | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 5.44e-18 | 29 | 200 | 11 | 20082482 |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 | 9.30e-18 | 9 | 200 | 8 | 7749980 | |
| Pubmed | Alternatively spliced forms of human killer inhibitory receptors. | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 | 9.30e-18 | 9 | 200 | 8 | 8662091 |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 1.12e-17 | 14 | 200 | 9 | 18945962 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5 KIR3DL1 | 4.63e-17 | 10 | 200 | 8 | 12559621 | |
| Pubmed | KIR2DL5B KIR2DL2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 | 4.63e-17 | 10 | 200 | 8 | 21206914 | |
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia]. | KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR2DL5A | 5.04e-16 | 12 | 200 | 8 | 17490516 |
| Pubmed | KIR haplotype content at the allele level in 77 Northern Irish families. | 1.49e-15 | 8 | 200 | 7 | 17200871 | |
| Pubmed | 6.67e-15 | 9 | 200 | 7 | 18340360 | ||
| Pubmed | 3.35e-14 | 6 | 200 | 6 | 20528243 | ||
| Pubmed | 3.35e-14 | 6 | 200 | 6 | 17882223 | ||
| Pubmed | 2.34e-13 | 7 | 200 | 6 | 14607943 | ||
| Pubmed | Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors. | 2.34e-13 | 7 | 200 | 6 | 11169255 | |
| Pubmed | 2.34e-13 | 7 | 200 | 6 | 9430220 | ||
| Pubmed | 9.30e-13 | 8 | 200 | 6 | 9430221 | ||
| Pubmed | 5.98e-12 | 5 | 200 | 5 | 16698429 | ||
| Pubmed | 5.98e-12 | 5 | 200 | 5 | 18755860 | ||
| Pubmed | 5.98e-12 | 5 | 200 | 5 | 12121272 | ||
| Pubmed | Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual. | 5.98e-12 | 5 | 200 | 5 | 10424431 | |
| Pubmed | 5.98e-12 | 5 | 200 | 5 | 19410616 | ||
| Pubmed | 5.98e-12 | 5 | 200 | 5 | 16112031 | ||
| Pubmed | 3.57e-11 | 6 | 200 | 5 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 3.57e-11 | 6 | 200 | 5 | 25930072 | |
| Pubmed | 3.30e-10 | 8 | 200 | 5 | 9548455 | ||
| Pubmed | 3.30e-10 | 8 | 200 | 5 | 15730517 | ||
| Pubmed | 7.40e-10 | 9 | 200 | 5 | 18074414 | ||
| Pubmed | 1.06e-09 | 4 | 200 | 4 | 21559424 | ||
| Pubmed | Recombinant structures expand and contract inter and intragenic diversification at the KIR locus. | 1.06e-09 | 4 | 200 | 4 | 23394822 | |
| Pubmed | 1.06e-09 | 4 | 200 | 4 | 18269867 | ||
| Pubmed | 1.06e-09 | 4 | 200 | 4 | 18632158 | ||
| Pubmed | 1.06e-09 | 4 | 200 | 4 | 25253288 | ||
| Pubmed | Killer-cell immunoglobulin-like receptors (KIR) in severe A (H1N1) 2009 influenza infections. | 1.06e-09 | 4 | 200 | 4 | 22652695 | |
| Pubmed | 1.06e-09 | 4 | 200 | 4 | 26542066 | ||
| Pubmed | Activating KIR genes are associated with ankylosing spondylitis in Asian populations. | 1.06e-09 | 4 | 200 | 4 | 18638658 | |
| Pubmed | 1.06e-09 | 4 | 200 | 4 | 19522772 | ||
| Pubmed | 1.06e-09 | 4 | 200 | 4 | 23354323 | ||
| Pubmed | HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding. | 1.06e-09 | 4 | 200 | 4 | 21270408 | |
| Interaction | KIR2DL2 interactions | 1.16e-09 | 13 | 193 | 6 | int:KIR2DL2 | |
| Interaction | LILRA3 interactions | 3.37e-08 | 11 | 193 | 5 | int:LILRA3 | |
| Interaction | KIR2DS3 interactions | 1.06e-06 | 20 | 193 | 5 | int:KIR2DS3 | |
| Interaction | KIR2DS2 interactions | 1.30e-06 | 37 | 193 | 6 | int:KIR2DS2 | |
| Interaction | KIR3DP1 interactions | 3.43e-06 | 4 | 193 | 3 | int:KIR3DP1 | |
| Interaction | KIR3DL1 interactions | 5.45e-06 | 13 | 193 | 4 | int:KIR3DL1 | |
| Interaction | KIR2DL1 interactions | 6.28e-06 | 28 | 193 | 5 | int:KIR2DL1 | |
| Interaction | HLA-C interactions | LILRB2 KIR2DS2 LILRB1 PI4KA KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 RAC1 RAC2 RAC3 CDH1 | 3.78e-05 | 353 | 193 | 13 | int:HLA-C |
| Interaction | MTNR1B interactions | 4.80e-05 | 135 | 193 | 8 | int:MTNR1B | |
| Cytoband | 19q13.4 | LILRB2 PEG3 KIR2DS2 LILRB1 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 LILRA1 LILRA3 LILRA2 LILRA4 | 2.31e-24 | 79 | 200 | 17 | 19q13.4 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | PSG3 LILRB2 PEG3 LILRB1 PNMA8B KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 NUDT19 LILRA1 LILRA2 KIR3DX1 WDR87 GARRE1 LILRA4 | 7.57e-05 | 1192 | 200 | 16 | chr19q13 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q23 | 4.96e-04 | 226 | 200 | 6 | chr1q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 5.20e-04 | 8 | 200 | 2 | chr9q12 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | KIR2DS2 KIR2DL5B KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 KIR3DX1 KIR2DL5A | 1.14e-24 | 18 | 136 | 13 | 620 |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | ERBB2 TNFSF13 LILRB2 KIR2DS2 ACE LILRB1 PROM1 NECTIN1 FGFR4 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 LILRA1 LILRA3 LILRA2 KIR2DL5A FCRL4 FCRL5 LY9 LY75 CDH1 IL4R LILRA4 IL9R | 1.21e-19 | 394 | 136 | 28 | 471 |
| GeneFamily | CD molecules|Activating leukocyte immunoglobulin like receptors | 4.54e-08 | 6 | 136 | 4 | 1181 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 1.66e-05 | 21 | 136 | 4 | 813 | |
| GeneFamily | Fibronectin type III domain containing | 2.85e-05 | 160 | 136 | 8 | 555 | |
| GeneFamily | Rho family GTPases | 4.32e-04 | 20 | 136 | 3 | 390 | |
| GeneFamily | CD molecules|Inhibitory leukocyte immunoglobulin like receptors | 5.53e-04 | 5 | 136 | 2 | 1182 | |
| GeneFamily | Neuroblastoma breakpoint family | 6.60e-04 | 23 | 136 | 3 | 662 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 1.15e-03 | 7 | 136 | 2 | 785 | |
| GeneFamily | PHD finger proteins|NuRD complex | 3.53e-03 | 12 | 136 | 2 | 1305 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.60e-03 | 41 | 136 | 3 | 1298 | |
| Coexpression | KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5 KIR3DL1 KIR2DL5A | 9.65e-11 | 49 | 196 | 9 | M40909 |
| Coexpression | SOUCEK_MYC_TARGETS | 1.08e-05 | 19 | 196 | 4 | MM1252 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_UP | INPP4A PKD1 OLFM1 GARIN1B ITPRIPL1 CDC42BPG RDH5 WDFY4 C6orf132 | 2.09e-05 | 200 | 196 | 9 | M9324 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO7B COL6A5 KIAA1549L PTPRZ1 PTPRQ HEPHL1 USH2A FRAS1 CECR2 ATP13A5 | 2.17e-09 | 160 | 193 | 10 | c381ec6be8cf887861cc18f831a20db42f953fe1 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO7B COL6A5 KIAA1549L PTPRZ1 PTPRQ HEPHL1 USH2A FRAS1 CECR2 ATP13A5 | 2.17e-09 | 160 | 193 | 10 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | NCAM2 COL6A5 PTPRD PTPRS SPON1 FGFR4 CACNA1D FRAS1 PIEZO2 PCOLCE | 1.85e-08 | 200 | 193 | 10 | aa1a35dcca3b799241eef4237f6eb94660e019f0 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | NCAM2 COL6A5 PTPRD PTPRS SPON1 FGFR4 CACNA1D FRAS1 PIEZO2 PCOLCE | 1.85e-08 | 200 | 193 | 10 | a510deaada669e690329183e18df02870bd204b3 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | NCAM2 COL6A5 PTPRD PTPRS SPON1 FGFR4 CACNA1D FRAS1 PIEZO2 PCOLCE | 1.85e-08 | 200 | 193 | 10 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | PCSK1 KIAA1549L PTPRQ HEPHL1 USH2A FRAS1 DPP10 ATP13A5 SUSD5 | 3.92e-08 | 162 | 193 | 9 | bf886e22ff2a20353499004b53f25fb9e6574896 |
| ToppCell | Adult-Epithelial-basal_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.24e-08 | 174 | 193 | 9 | a4f98afe7d1cc2617f6f7bc8092c41df57474b30 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.24e-08 | 174 | 193 | 9 | 3c47d069bd836599a8d40eae485c23d4d3487517 | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-07 | 181 | 193 | 9 | 3aa81ac64d0cc9a74fbfa71e2176740548e7cd06 | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-07 | 181 | 193 | 9 | 997ba1be2824b00d684f2163d0114656ed11fa53 | |
| ToppCell | 5'-Adult-Appendix-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-07 | 181 | 193 | 9 | e6b7e8dd5c13cc10ba22f2f5a8c669486f934bdc | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SERPINE2 PTPRD SPON1 SCN3A FGFR4 CACNA1D PLA2R1 PEAK1 PCOLCE | 1.06e-07 | 182 | 193 | 9 | c557de6ccd327c46e0a5423cd9936d78e0abae5f |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SERPINE2 PTPRD SPON1 SCN3A FGFR4 CACNA1D PLA2R1 PEAK1 PCOLCE | 1.06e-07 | 182 | 193 | 9 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 |
| ToppCell | Adult-Epithelial-basal_cell|Adult / Lineage, Cell type, age group and donor | TRPC6 SLC5A7 ST6GAL2 PTPRZ1 FRAS1 DPP10 GLB1L3 C2orf78 FAM83B | 1.11e-07 | 183 | 193 | 9 | 00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-07 | 195 | 193 | 9 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-07 | 195 | 193 | 9 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.00e-07 | 196 | 193 | 9 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.00e-07 | 196 | 193 | 9 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.09e-07 | 197 | 193 | 9 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | INPP4A NFATC2 TMC8 KIR2DL1 KIR2DL3 KIR3DL1 RAC2 KIR3DX1 SORL1 | 2.37e-07 | 200 | 193 | 9 | 56d738ff019682af7f1f8cbe7b262a75dc8596d5 |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | INPP4A NFATC2 TMC8 KIR2DL1 KIR2DL3 KIR3DL1 RAC2 KIR3DX1 SORL1 | 2.37e-07 | 200 | 193 | 9 | 7eed3d932018d6a87ce37d013883b371db55caeb |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.37e-07 | 200 | 193 | 9 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-07 | 166 | 193 | 8 | 66026988509e39e41274fa0de738383219e8ff30 | |
| ToppCell | Bronchial_Brush-Immune-B_cells|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.67e-07 | 169 | 193 | 8 | dc388f660f69e37e517bf3243daf071ab138ee6e | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-06 | 176 | 193 | 8 | 33323c97afe509147956b8df9f92ca6b0537e604 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-06 | 177 | 193 | 8 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-06 | 177 | 193 | 8 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-06 | 177 | 193 | 8 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.29e-06 | 181 | 193 | 8 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 1.40e-06 | 183 | 193 | 8 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | (7)_Epithelial-H_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.45e-06 | 184 | 193 | 8 | 1f76b37c265b519171b767a52d48f31f0cdc4a3c | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 184 | 193 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.45e-06 | 184 | 193 | 8 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 184 | 193 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 184 | 193 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | droplet-Pancreas|droplet / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-06 | 187 | 193 | 8 | 5f4df092452d8672bda4059c794e099ba3f5a8fa | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 190 | 193 | 8 | c247562df3e1aa3173c9f01a74d5831f0764a1b2 | |
| ToppCell | Dendritic_cell|World / shred by cell class for nasal brushing | 1.85e-06 | 190 | 193 | 8 | ae24934f45eea9c228bf6fe8cd0d6abca9eb208e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-06 | 190 | 193 | 8 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 190 | 193 | 8 | 5cea8298c8336c136ba009630c9e48d4bc832cb2 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.92e-06 | 191 | 193 | 8 | b5210de890d338602857b5907135705a507bc2b0 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.92e-06 | 191 | 193 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.92e-06 | 191 | 193 | 8 | 36467322096bc766cd777dae3bfb4e65511e492c | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.92e-06 | 191 | 193 | 8 | 94795daf05061baa3b72a1b01c9e940af86de044 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.92e-06 | 191 | 193 | 8 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.92e-06 | 191 | 193 | 8 | d4f535b06ad483448ab692e9900c872c78cbed60 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.00e-06 | 192 | 193 | 8 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.00e-06 | 192 | 193 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.00e-06 | 192 | 193 | 8 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.00e-06 | 192 | 193 | 8 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.08e-06 | 193 | 193 | 8 | 1b2cc627b2aa002b442358bd1188d470e67ce7d9 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.08e-06 | 193 | 193 | 8 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.08e-06 | 193 | 193 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | 18-Airway-Epithelial-Epithelial|Airway / Age, Tissue, Lineage and Cell class | 2.16e-06 | 194 | 193 | 8 | d3c90e1f1228f8ba0ba56105c6cf4f302c388f28 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-06 | 195 | 193 | 8 | b616ee6f1d878935d293c8e0a8bbc5b4385301f0 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-06 | 195 | 193 | 8 | 1c1135be421af98cd0077bec1ff2c4158d42aa21 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-06 | 195 | 193 | 8 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-06 | 195 | 193 | 8 | 11d421bbbb71425d59cbdd673e052e00d5f0a768 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-06 | 195 | 193 | 8 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-06 | 195 | 193 | 8 | 1f005ee1da66b539bd200aaa98f46edbbc7f12e4 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-06 | 195 | 193 | 8 | 2f9a274b26fc528a85f50933ec2f4db1dc9da0ca | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 2.24e-06 | 195 | 193 | 8 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-06 | 195 | 193 | 8 | 10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.33e-06 | 196 | 193 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.33e-06 | 196 | 193 | 8 | 97e26622d9582b092c18ff5b7e957818f99d9631 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.33e-06 | 196 | 193 | 8 | d3bd8fab010e76024d7e06aba0ea5df3394f411f | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.33e-06 | 196 | 193 | 8 | 77da6b1bcab45d376eb0368f540e0ed24ce98b42 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.33e-06 | 196 | 193 | 8 | 54f4cf778f95a9ff662e5c7520916a25e605bf95 | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.33e-06 | 196 | 193 | 8 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.33e-06 | 196 | 193 | 8 | f429f045ba45e24717963315832150b12a115bfa | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.42e-06 | 197 | 193 | 8 | 9993fdea353abeafc009ac87439ad25cedf8f1f6 | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.42e-06 | 197 | 193 | 8 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.42e-06 | 197 | 193 | 8 | 2744cc94883c5d0424677cf5093bbab622933e9b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.42e-06 | 197 | 193 | 8 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.42e-06 | 197 | 193 | 8 | a8b41fffa4e86f2766423392951ff320e821a19a | |
| ToppCell | Severe_COVID-19-T/NK-NK|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.42e-06 | 197 | 193 | 8 | cc20162892b59e48653981f91fc9a0c27064444d | |
| ToppCell | Severe-Lymphoid-NK|Severe / Condition, Lineage, Cell class and cell subclass | 2.51e-06 | 198 | 193 | 8 | 26b6d20527d22ce68067cdaea6b4330cb779f91b | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 2.51e-06 | 198 | 193 | 8 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 2.51e-06 | 198 | 193 | 8 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.51e-06 | 198 | 193 | 8 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.51e-06 | 198 | 193 | 8 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.51e-06 | 198 | 193 | 8 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.51e-06 | 198 | 193 | 8 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-06 | 198 | 193 | 8 | 800ade4261695f2efd869d2b1243571de963c431 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.51e-06 | 198 | 193 | 8 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.61e-06 | 199 | 193 | 8 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.61e-06 | 199 | 193 | 8 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.61e-06 | 199 | 193 | 8 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.61e-06 | 199 | 193 | 8 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Airway-Club|Control_saline / Treatment groups by lineage, cell group, cell type | 2.61e-06 | 199 | 193 | 8 | 5cc8b553a58669a30eb10845beb23983dcdf5a6a | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.61e-06 | 199 | 193 | 8 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.61e-06 | 199 | 193 | 8 | 655d07cf9a2fd9b945a2ed4f824cba0297de72a8 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.71e-06 | 200 | 193 | 8 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.71e-06 | 200 | 193 | 8 | cc6062dac07916c29091fc6bee2b864d29e6525b | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-06 | 200 | 193 | 8 | 7d90fcb5dfc4c9d562c93b0f9293ed12b5f4f404 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-06 | 200 | 193 | 8 | d2422aaf807010194994db97142b9fd2e807312d | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.71e-06 | 200 | 193 | 8 | 5c0716bf375c8158f7dc2c82bf5eaf37af594dd0 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-06 | 200 | 193 | 8 | d1cfc4ef6ae75c486427e393d98b84a2a7ec67fe | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-06 | 200 | 193 | 8 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-06 | 200 | 193 | 8 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| Computational | Porins / transporters. | ERBB2 LILRB2 GFRA3 PTPRS KIR2DL3 KIR3DL1 LILRA3 LILRA2 PLA2R1 IL4R | 4.59e-05 | 211 | 107 | 10 | MODULE_63 |
| Computational | Genes in the cancer module 27. | ERBB2 PSG3 LILRB2 GFRA3 PTPRS KIR2DL3 KIR3DL1 LILRA1 LILRA3 LILRA2 PLA2R1 IL4R | 2.06e-04 | 355 | 107 | 12 | MODULE_27 |
| Drug | D-Au | LILRB1 PYGL KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DX1 | 5.60e-11 | 77 | 195 | 11 | CID000277822 |
| Drug | NSC237521 | SPP1 LILRB1 JAK2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 RAG2 AP3B1 LY9 IL4R IL9R | 3.94e-09 | 210 | 195 | 14 | CID000428410 |
| Drug | IL-T | 2.51e-08 | 56 | 195 | 8 | CID000150551 | |
| Drug | Aa1 | KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DX1 | 3.92e-08 | 83 | 195 | 9 | CID009549188 |
| Drug | AC1L1AQK | TNFSF13 SREBF1 NPC1L1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 | 8.86e-07 | 119 | 195 | 9 | CID000001105 |
| Drug | B258 | 1.21e-05 | 6 | 195 | 3 | CID000593690 | |
| Disease | autosomal dominant intellectual developmental disorder 48 (implicated_via_orthology) | 2.27e-07 | 3 | 181 | 3 | DOID:0080235 (implicated_via_orthology) | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 1 measurement | 1.77e-06 | 15 | 181 | 4 | EFO_0008208 | |
| Disease | Ovarian Carcinoma | 3.31e-05 | 30 | 181 | 4 | C0029925 | |
| Disease | Connective Tissue Diseases | 6.21e-05 | 13 | 181 | 3 | C0009782 | |
| Disease | stomach cancer (is_implicated_in) | 8.24e-05 | 72 | 181 | 5 | DOID:10534 (is_implicated_in) | |
| Disease | level of killer cell immunoglobulin-like receptor 2DS2 in blood serum | 1.12e-04 | 3 | 181 | 2 | OBA_2042107 | |
| Disease | secretory phospholipase A2 receptor measurement | 1.12e-04 | 3 | 181 | 2 | EFO_0802043 | |
| Disease | kidney disease (implicated_via_orthology) | 1.16e-04 | 41 | 181 | 4 | DOID:557 (implicated_via_orthology) | |
| Disease | prostate cancer (biomarker_via_orthology) | 2.23e-04 | 4 | 181 | 2 | DOID:10283 (biomarker_via_orthology) | |
| Disease | Fc receptor-like protein 4 measurement | 2.23e-04 | 4 | 181 | 2 | EFO_0801599 | |
| Disease | Usher syndrome (is_implicated_in) | 2.23e-04 | 4 | 181 | 2 | DOID:0050439 (is_implicated_in) | |
| Disease | lung adenocarcinoma (is_implicated_in) | 2.34e-04 | 49 | 181 | 4 | DOID:3910 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | ERBB2 ERCC6 AKAP8 SPP1 SERPINE2 PTPRD BRCA2 FAM83F RAC2 UBR4 EPG5 ZNF436 CHD5 FCRL5 CDH1 CUX1 SORL1 | 3.51e-04 | 1074 | 181 | 17 | C0006142 |
| Disease | Carcinoma of lung | 3.67e-04 | 23 | 181 | 3 | C0684249 | |
| Disease | lung carcinoma (is_marker_for) | 3.70e-04 | 5 | 181 | 2 | DOID:3905 (is_marker_for) | |
| Disease | chronic fatigue syndrome (is_implicated_in) | 3.70e-04 | 5 | 181 | 2 | DOID:8544 (is_implicated_in) | |
| Disease | heptanoate 7:0 measurement | 3.70e-04 | 5 | 181 | 2 | EFO_0021104 | |
| Disease | ovarian cancer (is_implicated_in) | 3.92e-04 | 56 | 181 | 4 | DOID:2394 (is_implicated_in) | |
| Disease | Neoplasm of the genitourinary tract | 4.18e-04 | 24 | 181 | 3 | cv:C0042065 | |
| Disease | Colorectal Carcinoma | ERCC6 TNFSF13 PEG3 PROM1 PTPRD TOMM40L PTPRS CHD5 DCHS1 CDH1 DCLK1 CUX1 SORL1 | 4.20e-04 | 702 | 181 | 13 | C0009402 |
| Disease | heart rate | 5.00e-04 | 225 | 181 | 7 | EFO_0004326 | |
| Disease | Heart valve disease | 5.32e-04 | 26 | 181 | 3 | C0018824 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 5.32e-04 | 26 | 181 | 3 | DOID:234 (is_implicated_in) | |
| Disease | calcinosis (is_marker_for) | 5.52e-04 | 6 | 181 | 2 | DOID:182 (is_marker_for) | |
| Disease | hepatocellular carcinoma (is_marker_for) | 5.70e-04 | 301 | 181 | 8 | DOID:684 (is_marker_for) | |
| Disease | azoospermia (implicated_via_orthology) | 5.96e-04 | 27 | 181 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | tuberculosis (is_implicated_in) | 6.64e-04 | 28 | 181 | 3 | DOID:399 (is_implicated_in) | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 7.38e-04 | 29 | 181 | 3 | C0496920 | |
| Disease | 1,5 anhydroglucitol measurement | 7.38e-04 | 29 | 181 | 3 | EFO_0008009 | |
| Disease | Ovarian neoplasm | 7.70e-04 | 7 | 181 | 2 | cv:C0919267 | |
| Disease | Helicobacter Infections | 7.70e-04 | 7 | 181 | 2 | C0079487 | |
| Disease | invasive lobular carcinoma (is_marker_for) | 7.70e-04 | 7 | 181 | 2 | DOID:3457 (is_marker_for) | |
| Disease | amyotrophic lateral sclerosis (implicated_via_orthology) | 8.16e-04 | 30 | 181 | 3 | DOID:332 (implicated_via_orthology) | |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 8.16e-04 | 30 | 181 | 3 | C1868672 | |
| Disease | melanoma | 8.86e-04 | 248 | 181 | 7 | C0025202 | |
| Disease | Non-alcoholic Fatty Liver Disease | 9.16e-04 | 70 | 181 | 4 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 9.16e-04 | 70 | 181 | 4 | C3241937 | |
| Disease | lung cancer (is_implicated_in) | 1.13e-03 | 74 | 181 | 4 | DOID:1324 (is_implicated_in) | |
| Disease | Unipolar Depression | 1.14e-03 | 259 | 181 | 7 | C0041696 | |
| Disease | mitral valve prolapse (is_implicated_in) | 1.31e-03 | 9 | 181 | 2 | DOID:988 (is_implicated_in) | |
| Disease | renovascular hypertension (implicated_via_orthology) | 1.31e-03 | 9 | 181 | 2 | DOID:1591 (implicated_via_orthology) | |
| Disease | Chronic schizophrenia | 1.31e-03 | 9 | 181 | 2 | C0221765 | |
| Disease | acquired immunodeficiency syndrome (is_implicated_in) | 1.31e-03 | 9 | 181 | 2 | DOID:635 (is_implicated_in) | |
| Disease | Glioma | 1.31e-03 | 9 | 181 | 2 | cv:C0017638 | |
| Disease | Malignant tumor of prostate | 1.31e-03 | 9 | 181 | 2 | cv:C0376358 | |
| Disease | Cleft palate with cleft lip | 1.31e-03 | 9 | 181 | 2 | C0158646 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.33e-03 | 195 | 181 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | ovarian neoplasm | 1.45e-03 | 134 | 181 | 5 | C0919267 | |
| Disease | Malignant neoplasm of ovary | 1.60e-03 | 137 | 181 | 5 | C1140680 | |
| Disease | interstitial lung disease (is_implicated_in) | 1.63e-03 | 10 | 181 | 2 | DOID:3082 (is_implicated_in) | |
| Disease | human immunodeficiency virus infectious disease (is_implicated_in) | 1.76e-03 | 39 | 181 | 3 | DOID:526 (is_implicated_in) | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 2 measurement | 1.98e-03 | 11 | 181 | 2 | EFO_0008209 | |
| Disease | Mammary Ductal Carcinoma | 1.98e-03 | 11 | 181 | 2 | C0021367 | |
| Disease | Invasive Ductal Breast Carcinoma | 1.98e-03 | 11 | 181 | 2 | C1134719 | |
| Disease | Proteinuria | 2.34e-03 | 43 | 181 | 3 | C0033687 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 2.34e-03 | 43 | 181 | 3 | DOID:9261 (is_marker_for) | |
| Disease | liver cirrhosis (is_implicated_in) | 2.34e-03 | 43 | 181 | 3 | DOID:5082 (is_implicated_in) | |
| Disease | interleukin 7 measurement | 2.67e-03 | 45 | 181 | 3 | EFO_0008189 | |
| Disease | hematologic cancer (implicated_via_orthology) | 2.79e-03 | 13 | 181 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | drug use measurement, depressive symptom measurement, SSRI use measurement | 2.79e-03 | 13 | 181 | 2 | EFO_0007006, EFO_0007010, EFO_0007011 | |
| Disease | Carcinogenesis | 2.79e-03 | 13 | 181 | 2 | C0596263 | |
| Disease | leukemia (is_implicated_in) | 2.79e-03 | 13 | 181 | 2 | DOID:1240 (is_implicated_in) | |
| Disease | Pneumoconiosis | 3.24e-03 | 14 | 181 | 2 | C0032273 | |
| Disease | Bagassosis | 3.24e-03 | 14 | 181 | 2 | C0004681 | |
| Disease | Childhood Ataxia with Central Nervous System Hypomyelinization | 3.24e-03 | 14 | 181 | 2 | C1858991 | |
| Disease | Neoplasm of lung | 3.24e-03 | 14 | 181 | 2 | cv:C0024121 | |
| Disease | myocarditis (implicated_via_orthology) | 3.24e-03 | 14 | 181 | 2 | DOID:820 (implicated_via_orthology) | |
| Disease | Lung cancer | 3.24e-03 | 14 | 181 | 2 | cv:C0242379 | |
| Disease | Impaired cognition | 3.24e-03 | 14 | 181 | 2 | C0338656 | |
| Disease | LUNG CANCER | 3.24e-03 | 14 | 181 | 2 | 211980 | |
| Disease | low density lipoprotein cholesterol measurement, response to selective serotonin reuptake inhibitor | 3.73e-03 | 15 | 181 | 2 | EFO_0004611, EFO_0005658 | |
| Disease | cleft lip (is_implicated_in) | 3.73e-03 | 15 | 181 | 2 | DOID:9296 (is_implicated_in) | |
| Disease | killer cell immunoglobulin-like receptor 2DS2 measurement | 3.73e-03 | 15 | 181 | 2 | EFO_0801746 | |
| Disease | sitting height ratio | 3.81e-03 | 51 | 181 | 3 | EFO_0007118 | |
| Disease | Retinitis Pigmentosa | 3.91e-03 | 104 | 181 | 4 | C0035334 | |
| Disease | Major Depressive Disorder | 3.98e-03 | 243 | 181 | 6 | C1269683 | |
| Disease | pancreatitis | 4.24e-03 | 16 | 181 | 2 | EFO_0000278 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 4.24e-03 | 16 | 181 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | Benign neoplasm of stomach | 4.79e-03 | 17 | 181 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 4.79e-03 | 17 | 181 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 4.79e-03 | 17 | 181 | 2 | C0154060 | |
| Disease | glomerulonephritis (implicated_via_orthology) | 4.79e-03 | 17 | 181 | 2 | DOID:2921 (implicated_via_orthology) | |
| Disease | urate measurement, bone density | TRPC6 COL6A5 PTPRD A2ML1 OLFM1 USH2A RASAL1 FRAS1 PEAK1 DCLK1 | 5.08e-03 | 619 | 181 | 10 | EFO_0003923, EFO_0004531 |
| Disease | Alzheimer's disease (implicated_via_orthology) | 5.21e-03 | 57 | 181 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | IGA glomerulonephritis | 5.47e-03 | 58 | 181 | 3 | EFO_0004194 | |
| Disease | lifestyle measurement, alcohol consumption measurement | 5.58e-03 | 115 | 181 | 4 | EFO_0007878, EFO_0010724 | |
| Disease | multiple myeloma (is_implicated_in) | 5.74e-03 | 59 | 181 | 3 | DOID:9538 (is_implicated_in) | |
| Disease | insulin resistance | 5.74e-03 | 59 | 181 | 3 | EFO_0002614 | |
| Disease | Carcinoma, Granular Cell | 5.75e-03 | 116 | 181 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 5.75e-03 | 116 | 181 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 5.75e-03 | 116 | 181 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 5.75e-03 | 116 | 181 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 5.75e-03 | 116 | 181 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 5.75e-03 | 116 | 181 | 4 | C0001418 | |
| Disease | prostate cancer (is_implicated_in) | 5.93e-03 | 117 | 181 | 4 | DOID:10283 (is_implicated_in) | |
| Disease | ankylosing spondylitis (is_implicated_in) | 5.97e-03 | 19 | 181 | 2 | DOID:7147 (is_implicated_in) | |
| Disease | anorectal malformation | 5.97e-03 | 19 | 181 | 2 | MONDO_0019938 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PDEPLTWQYVDQFVS | 176 | Q9Y6N9 | |
| IASSPDYEFNVWTRP | 46 | Q8NDL9 | |
| DVSVVLPENPITYAW | 346 | Q9GZN1 | |
| SYEDPPTAKAAVEWF | 416 | Q01844 | |
| YISAWPDSLPDLSVF | 411 | P04626 | |
| PLYLWQPSASEIAVI | 861 | Q9HCE0 | |
| SPVWDYFVASPLQDE | 1041 | Q96N23 | |
| EDSTWPPINRTDYSG | 1166 | Q4VNC0 | |
| RTNSTPPVAASYVWD | 2096 | Q7Z408 | |
| LADITTWVEDTYLPP | 441 | A6NCI8 | |
| PYLVSAPLSTIINWE | 751 | Q8TDI0 | |
| QTWSNIYDLVVPFPS | 886 | P12821 | |
| SSEPLSTPWNELNYV | 216 | O43823 | |
| EWPSAESPYSQSSEL | 881 | P39880 | |
| ILSDWSTYPELQLPT | 236 | Q96PJ5 | |
| PTWTAAAPEARYTDI | 356 | P22455 | |
| WSEPAAVDVELTAYA | 1186 | A8K2U0 | |
| EDPYAISFSPWNPSV | 231 | Q9H8T0 | |
| YSSLPSQPLDPSNWA | 176 | A6NJG6 | |
| TTVWEDQLSYLLSPA | 546 | Q8TAP6 | |
| YWPADPEISLLTEAS | 151 | Q9BWV3 | |
| SWPFLEPVDESYAPN | 456 | Q9BXF3 | |
| APLTSFDWNEVDPYL | 121 | P61962 | |
| PSWEEDYTPVSDSLN | 431 | Q9Y2H0 | |
| NPPEVEDSVLQYAAW | 171 | Q8N608 | |
| ANRVVIYDPDWNPST | 926 | Q03468 | |
| TGYLELSNWPEVAPD | 631 | O00203 | |
| FWPSLPTGIQAAYED | 321 | P22894 | |
| AFSLLAYSDPWNSPV | 651 | Q96S59 | |
| PTCDVDINTWVPFYS | 421 | P55895 | |
| WSDPLDPDAEAQTVY | 716 | O95294 | |
| YPDAVATWLNPDPSQ | 36 | P10451 | |
| WLSYELQPETASASI | 606 | Q9Y5H5 | |
| AQGTLTTPNWPESDY | 166 | Q15113 | |
| SPASYENVRAKWFPE | 86 | P15153 | |
| SPASFENVRAKWYPE | 86 | P60763 | |
| SPASFENVRAKWYPE | 86 | P63000 | |
| QTPYFWTSTLRPAAE | 106 | O94810 | |
| YQTSPDGDPVAESVW | 441 | P21918 | |
| SPIFWYAPESLTESK | 1016 | O60674 | |
| TIKEESNPVPYNSSW | 291 | P14316 | |
| PYEWSNSSDPLLVSV | 206 | P43631 | |
| SSPGEWSEALYPLLT | 621 | Q96PE3 | |
| DWERLASSTAPYIPE | 341 | Q6DT37 | |
| ENINVSYPEWLSPEE | 461 | Q92542 | |
| SYPEWLSPEEDLNFV | 466 | Q92542 | |
| SPEIAASLWQSLEYT | 656 | Q92621 | |
| PYEWSDPSDPLLVSV | 201 | Q8N109 | |
| NSPYVWSLPSDLLEL | 201 | Q8N149 | |
| SEESFWIPATPYISN | 141 | Q9Y442 | |
| WNLSNPDPTSSEYIT | 14211 | Q8WXI7 | |
| PLEWPLSSQSGSYEL | 396 | Q13469 | |
| NDVDSGPVLWYVLSP | 2301 | Q96JQ0 | |
| VTDPWVTQPVNLADY | 1246 | Q96RG2 | |
| PYEWSNSSDPLLVSV | 206 | P43627 | |
| PYEWSNSSDPLLVSV | 206 | P43632 | |
| DVAEYSLFPNSPKWT | 91 | P09237 | |
| WSEPSDPLELVVTAY | 106 | P59901 | |
| LAYVDDSSPDPEIWI | 1736 | Q86XX4 | |
| DSSPDPEIWIQLNYL | 1741 | Q86XX4 | |
| TWHALPESESLPRYA | 441 | Q8TD91 | |
| LAEVVGYQWSSPSEA | 231 | A8MXV4 | |
| PYEWSNSSDPLLVSV | 206 | P43628 | |
| EPWLSQPASGSAYAT | 86 | Q8NC56 | |
| FNTVTTYVPWNLHEP | 116 | Q8NCI6 | |
| EVYLREAPWPSAQSE | 1366 | Q14C86 | |
| VDFPSPYWDNVSDSA | 606 | O15075 | |
| RWVYPLTPEANFTDS | 316 | Q13144 | |
| TYWPVESDVEAPNLD | 91 | Q5T0W9 | |
| PYEWSDPSDPLLVSV | 201 | Q8NHK3 | |
| PYEWSDPSDPLLVSV | 301 | P43629 | |
| DSDSQEPTYHNVPAW | 891 | Q96RD9 | |
| FDLLEPSTWPYEEIT | 631 | Q9HCI6 | |
| PTYDIDPNWDASSAG | 1186 | Q9H792 | |
| PLSVSPARWAEEYLE | 151 | P50542 | |
| VLPTNPEESWQVYSS | 51 | Q99784 | |
| TSRADWTGDEPLPYQ | 371 | Q8TE67 | |
| ASGELSPELQEWAPY | 1141 | Q8TDM6 | |
| WYNPLSAPELELDQA | 1506 | P42356 | |
| KPYVTESPAEDSNWV | 486 | Q8N8W4 | |
| LNSPYVWSSPSDLLE | 201 | Q8N423 | |
| EVTLTYWDENEPNVP | 441 | O60449 | |
| PYEWSKSSDPLLVSV | 206 | Q14952 | |
| TSAPNDLWYNFIELP | 231 | P07093 | |
| SQWADSVPLPGYIEA | 1751 | Q6ZVL6 | |
| DPENYTSLLVTWERP | 321 | P23471 | |
| WSYSVPSLNSEQEDP | 1451 | Q9Y4D8 | |
| TRSYPTFPSLNAWEE | 21 | Q96KD3 | |
| HSRYEWSAPSDPLDI | 201 | Q9H7L2 | |
| APPNVDPEAYSWFQS | 111 | Q9UBV8 | |
| NYEWSVIRSLAPTDP | 1001 | Q9GZU2 | |
| SWYLDNTPTEQAEPL | 696 | Q7Z442 | |
| PYEWSKSSDPLLVSV | 206 | Q14953 | |
| NISSSSILLYWDPPE | 621 | Q9UMZ3 | |
| DHNIPYKWTAPEALS | 346 | Q13882 | |
| LLSWEFPDNYNSPTP | 1051 | Q13332 | |
| IYDPADISEGSTALW | 206 | Q86UW1 | |
| PEQSYLAIPASSWVD | 941 | Q9UHC9 | |
| VPVTSYNWLTDFPSQ | 151 | Q6GPH6 | |
| SLYATNPPWIFTQEA | 26 | Q5T0Z8 | |
| AAYVFPAESWLVPAT | 231 | Q96QU4 | |
| QAAYVFPAESWLVPA | 231 | A6NGY1 | |
| AAYVFPAESWLVPAT | 231 | Q64ET8 | |
| LVDLYPSNPVSWFAV | 291 | Q13042 | |
| PSWAAEDIINYTEPK | 2496 | Q9ULT8 | |
| SDTLLLTWSNPYPPD | 136 | P24394 | |
| WFEELSSEAPPYNSE | 31 | P51587 | |
| LDVSPYEDTVTSKPW | 131 | O60609 | |
| PPTIYSDNTLEQWLD | 116 | Q8WW52 | |
| DPSTLLPSSLDFWTY | 181 | P00915 | |
| TAVQTPDPAFTYEWT | 531 | Q9H6X5 | |
| ALLWTTENLFPETPY | 2061 | A8TX70 | |
| APLYAVTSPGSQWND | 996 | O15063 | |
| TPEKWSAQAIPEASY | 391 | Q86WZ0 | |
| SLNVPSTESYWILPN | 281 | Q5VV63 | |
| TWLTYTDSDAPPSAA | 26 | Q8WXS3 | |
| EYAPTPADANCLTWV | 171 | Q6MZM0 | |
| SVLYSWTPREPHASE | 186 | Q9HBG7 | |
| LDSSSPEQTVPYLWS | 3961 | Q14204 | |
| VYSPEADQWTALPRL | 51 | Q8IYD2 | |
| NTLTTYVPWNLHEPE | 91 | Q8IW92 | |
| AIWNVDLSTSSYPIA | 2291 | A6NE01 | |
| ATADTVIIYDSDWNP | 1136 | Q14839 | |
| EWSEDPIPESVIQNY | 271 | Q15020 | |
| PAAEETAAWVLPFTS | 311 | Q96H72 | |
| EPQWSLYPSDSQVSE | 136 | P05060 | |
| PYEWSKSSDPLLVSV | 206 | P43626 | |
| NDLPISSYPGSDSWA | 386 | Q9P1A2 | |
| LPSLHRSSWYTDEPD | 2016 | Q01668 | |
| ADAPNTPAWEAVYTI | 401 | P12830 | |
| QDWSHAAAYVTVPPL | 286 | Q9BPU6 | |
| YNLSSEWSAPSDPLD | 301 | Q8N6C8 | |
| PWETNDTLFSVVALP | 886 | P98161 | |
| ADSNPPAEYSWTING | 356 | Q16557 | |
| WTPPRSDTIANYELV | 536 | P23468 | |
| PYEWSKSSDPLLVSV | 206 | Q14954 | |
| QIAAAEPWPENATLY | 11 | O75431 | |
| DFTPEPDSYDVIWIQ | 121 | Q9BV86 | |
| ASTDWNQTAYGLPDP | 296 | Q9GZV3 | |
| SYSPDSFNVSWTEPE | 2251 | O75445 | |
| EDDTPETCIYSNWSP | 436 | Q9HCB6 | |
| TSVVIKWESPYDSPD | 1946 | Q92673 | |
| PVVSSSDESWLDGYP | 361 | O60279 | |
| AVSQVSLYSWPVPES | 226 | Q15345 | |
| YNLSSEWSAPSDPLD | 301 | O75019 | |
| DSNSPYEWSLPSDLL | 201 | Q8NHL6 | |
| VPQESWDEGYSTPSI | 556 | P0DPF3 | |
| PQESWDEGYSTLSIP | 286 | Q8N660 | |
| PQESWDEGYSTLSIP | 286 | A0A087WUL8 | |
| AWVTDRSYTLQSPPF | 431 | Q5VVP1 | |
| EFVAIVAYTDPSDPW | 331 | Q9ULN7 | |
| PYEWSDPSDPLLVSV | 301 | Q14943 | |
| AWVTDRSYTLQSPPF | 431 | Q8IWB4 | |
| ESWNPVPYSVASAAI | 726 | Q8TE76 | |
| TDAPKAWNYELPATN | 26 | O43490 | |
| ILVAWDPAPYSANLN | 366 | Q96JF0 | |
| TVDWSSFPPQQYLLT | 371 | Q9BXB7 | |
| TLSNPPDWTKNVEYT | 146 | Q9NY46 | |
| LERPAVQAWSPASQY | 6 | Q9NQW1 | |
| PAYSRWQDPIFSLAT | 331 | Q9NRC8 | |
| AYLPQEDWAPTSLTR | 406 | Q01113 | |
| WLPASYLPASLVDAV | 291 | Q92781 | |
| ALRAAWSPYEDAVPA | 66 | Q8NEG4 | |
| SDGTPLNYLNWSPEV | 306 | Q13018 | |
| YSNWSPFDIINIPSH | 1041 | Q13018 | |
| YLLPAIDWDTSALAP | 176 | Q96JT2 | |
| IDWDTSALAPYLGTQ | 181 | Q96JT2 | |
| STPWESLYSLAGNPV | 781 | P36956 | |
| LPSELTLWVDPYEVS | 96 | P78543 | |
| ETLTSWSLATDPSYP | 591 | Q5T9A4 | |
| AWVTDRSYTLQSPPF | 431 | Q5VYP0 | |
| PVDYLPDNRTWSEVS | 726 | Q92738 | |
| TNYSAPWQVVPELVA | 566 | Q8IU68 | |
| AEEWVSYPLQPVTDL | 111 | Q9C0F3 | |
| PVDAWTLAFSPDSQY | 106 | Q9GZS3 | |
| EDSPSCPSLYANWLV | 941 | Q9NZQ8 | |
| SPAPAVSWLYHNEEV | 141 | O15394 | |
| AWVTDRSYTLQSPPF | 431 | Q5TZJ5 | |
| TAYPASPREWTSIEA | 56 | P60508 | |
| AWVTDRSYTLQSPPF | 431 | Q5VU36 | |
| PRDVPESFTSEAYQW | 636 | Q8IWA0 | |
| SPWEIYITLHPATAE | 41 | Q96BH1 | |
| NPYWTALPSTLENAT | 46 | Q8TCT8 | |
| STPQYRWEPSDESSE | 446 | Q9H5I5 | |
| PVFPWVLADYTSETL | 2571 | Q6ZS81 | |
| KSAFVRTQWPSPEEY | 676 | Q9UKY1 | |
| LYWDDPVDLQPSSVS | 1416 | Q8IWV7 | |
| LAPSSLVLPAVDWYA | 126 | Q15904 | |
| TAEPPYTALADWTLR | 991 | Q9P2J2 | |
| NEISPSLYAAPWFLT | 1076 | O60343 | |
| WVLAEPAENSDFYLP | 16 | Q8TE23 | |
| AYAGDWQLSPTEVFP | 81 | Q969M1 | |
| WDPSDPQIISEGLYA | 586 | Q9Y210 | |
| VENTSYWLQPSLQPS | 2246 | Q5T4S7 | |
| WIDTQVVLALPYDTP | 216 | P06737 | |
| PFSILDQAVDWAYDP | 366 | Q6ZQQ6 | |
| AWSASTLQPPVAYIL | 206 | O95416 | |
| EGYPWQSLPEQSSDA | 76 | O75888 | |
| PNYSSSLWGVPTVED | 1796 | Q9UPQ9 | |
| EAYEPTTNTWTLLPH | 841 | Q96CT2 | |
| YDPETDTWTSQGQLP | 546 | Q2WGJ6 | |
| LSSPDETFPNSWYLP | 226 | Q9UQQ1 | |
| YPSRQAWPTLELTDQ | 1681 | Q6PIF6 | |
| VVWTSEYDPLANNPG | 411 | P29120 | |
| ADANPPATEYHWTTL | 271 | Q15223 |